首页> 外文期刊>Annals of Nuclear Medicine and Molecular Imaging >Progress and Prospects of Radiopharmaceuticals in the World (II): Latest National Nomenclature Guideline for Radiopharmaceuticals and Radiochemistry
【24h】

Progress and Prospects of Radiopharmaceuticals in the World (II): Latest National Nomenclature Guideline for Radiopharmaceuticals and Radiochemistry

机译:世界放射性药物的进展与前景(II):最新的放射性药物和放射化学的国家命名准则

获取原文
获取原文并翻译 | 示例
           

摘要

Over recent years, there are much frequently occasions for scientific and technical communication with the growing of radiochemical and radiopharmaceutical fields. However, there are also an increased incidence of incorrect usage of established scientific terms and conventions. To ensure that spoken or written scientific terms and concepts leave no ambiguity in their interpretation and to provide a source literature for terminological harmonization, an international Working Group of European Association of Nuclear Medicine (EANM) was established in 2015 and organized a guidelines representing a consensus of the wider field of radiopharmaceutical sciences.
机译:近年来,与不断增长的放射化学和放射性药领域的科学和技术沟通有很多频繁的场合。 但是,既定科学术语和公约的错误使用情况也增加了不正确的发生率。 为了确保口语或书面科学术语和概念在其解释中没有歧义,并为欧洲核医学协会(EANM)的国际工作组成立,为术语协调提供了术语统一的源事学,并组织了代表共识的指导方针 放射性药物科学的更广泛的领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号